Save time and get answers to complex questions with AI chat
Xiaflex market launch year?Guselkumab brand name?Zemdri nce gain exclusivity 2028 patent 2031?What is the difference between apixaban and apixaban accord?Patent tenofovir alafenamide gilead?
See the DrugPatentWatch profile for Alteplase
Alteplase is classified as a thrombolytic (fibrinolytic) medicine—specifically a tissue plasminogen activator (tPA). It works by activating plasminogen to help break down blood clots.
As a recombinant form of human tPA, alteplase promotes conversion of plasminogen into plasmin, which degrades fibrin in a clot. This is why it’s used for acute, time-sensitive thrombotic conditions such as ischemic stroke and certain forms of vascular thrombosis.
People use “classification” in a few different ways: - Therapeutic/clinical class: thrombolytic (tPA) - Mechanism-based description: tissue plasminogen activator - Coding systems (like ATC): varies by country and the exact product labeling If you tell me whether you need the ATC code (or another system like FDA/USP classification), I can format the answer to match that system.
Other Questions About Alteplase :